NCT02657512View on ClinicalTrials.gov

Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 29, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

rivaroxaban

rivaroxaban 40 mg/day (1 day)

DRUG

rivaroxaban and activated charcoal

rivaroxaban 40 mg/day (1 day) and 50 g of activated charcoal 2 or 5 or 8 hours after rivaroxaban administration (1 day)

Trial Locations (1)

42000

CHU de SAINT-ETIENNE, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02657512 - Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects | Biotech Hunter | Biotech Hunter